BION.SW

Healthcare Biotechnology

BB Biotech AG

CHF 50.30

-0.50 -0.98% today

Price History

Not enough data

Key Stats

Market Cap

2.77B

Avg Volume

83,293

P/E (TTM)

2.05

EPS

CHF 24.57

52W High

CHF 57.00

52W Low

CHF 37.20

Div. Yield

4.4%

Analyst Ratings

Buy

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

-76.47

P/B Ratio

0.90

P/S Ratio

2.62

EV/Revenue

-0.28

Margins

Gross Margin 100.0%

Operating Margin 97.7%

Net Margin 127.3%

EBITDA Margin 0.0%

Growth & Returns

Revenue Growth (YoY)

116257.7%

Return on Equity

54.8%

Return on Assets

25.9%

Liquidity & Leverage

Current Ratio

583.97

Quick Ratio

583.91

Total Cash

3.08B

Total Debt

About

BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.